Balancing collective responsibility, individual opportunities and risks: A qualitative study on how police officers reason around volunteering in an HIV vaccine trial in Dar es Salaam, Tanzania

BMC Public Health

Volumn 10, Issue , 2010, Pages

  Tarimo, Edith Am ^a,b   Thorson, Anna ^a   Kohi, Thecla W ^b   Mwami, Joachim ^c   Bakari, Muhammad ^b   Sandström, Eric ^a   Kulane, Asli ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b MUHIMBILI UNIVERSITY OF HEALTH AND ALLIED SCIENCES   (Tanzania)

^c UNIVERSITY OF DAR ES SALAAM   (Tanzania)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS VACCINE;

ADULT; ALTRUISM; ARTICLE; CLINICAL TRIAL (TOPIC); FEAR; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFORMATION PROCESSING; MALE; MOTIVATION; PATIENT PARTICIPATION; POLICE; QUALITATIVE RESEARCH; RISK; TANZANIA;

ADULT; AIDS VACCINES; ALTRUISM; CLINICAL TRIALS AS TOPIC; FEAR; FEMALE; FOCUS GROUPS; HIV INFECTIONS; HUMANS; MALE; MOTIVATION; PATIENT PARTICIPATION; POLICE; QUALITATIVE RESEARCH; RISK; TANZANIA;

EID: 77952713428     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-10-292     Document Type: Article

References (44)

1. Local understanding of an HIV vaccine and its relationship with HIV-related stigma in the Dominican Republic. C Barrington L Moreno D Kerrigan, AIDS Care 2007 19 871 877 10.1080/09540120701203295 17712690
2. Motivations for participating in an HIV vaccine efficacy trial. G Colfax S Buchbinder G Vamshidar C Celum D McKirnan J Neidig B Koblin M Gurwith B Bartholow, J Acquir Immune Defic Syndr 2005 39 359 364 10.1097/01.qai. 0000152039.88422.ec 15980699
3. HIV vaccine preparedness studies in the organization for economic co-operation and development (OECD) countries. S Dhalla R Woods SA Strathdee DM Patrick RS Hogg, AIDS Care 2007 19 1118 1127 10.1080/09540120701352258 17851989
4. HIV vaccine trial participation among ethnic minority communities: barriers, motivators, and implications for recruitment. PA Newman N Duan KJ Roberts D Seiden ET Rudy D Swendeman S Popova, J Acquir Immune Defic Syndr 2006 41 210 217 10.1097/01.qai.0000179454.93443.60 16394854
5. Community members' perceptions of enablers and inhibitors to participation in HIV vaccine trials. A Lesch Z Kafaar L Swartz, S Afr J Psychol 2006 36 734 761
6. Local knowledge and experiences of vaccination: implications for HIV-preventive vaccine trials in South Africa. G Lindegger M Quayle M Ndlovu, Health Educ Behav 2007 34 108 123 10.1177/1090198105277852 16740504
7. Racial and ethnic differences in knowledge and willingness to participate in HIV vaccine trials in an urban population in the south-eastern US. FH Priddy AC Cheng LF Salazar PM Frew, Int J STD AIDS 2006 17 99 102 10.1258/ 095646206775455667 16464270
8. Factors affecting African-American participation in AIDS research. S Sengupta RP Strauss R DeVellis SC Quinn B DeVellis WB Ware, J Acquir Immune Defic Syndr 2000 24 275 284 10969353
9. Pediatric HIV type 1 vaccine trial acceptability among mothers in Kenya. C Farquhar GC John-Stewart FN John MN Kabura JN Kiarie, AIDS Res Hum Retroviruses 2006 22 491 495 10.1089/aid.2006.22.491 16796522
10. Knowledge about vaccines and willingness to participate in preventive HIV vaccine trials: a population-based study, Rakai, Uganda. N Kiwanuka M Robb G Kigozi D Birx J Philips F Wabwire-Mangen MJ Wawer F Nalugoda NK Sewankambo D Serwadda RH Gray, J Acquir Immune Defic Syndr 2004 36 721 725 10.1097/00126334-200406010-00009 15167291
11. Knowledge about vaccine trials and willingness to participate in an HIV/AIDS vaccine study in the Ugandan military. JW McGrath K George G Svilar E Ihler D Mafigiri M Kabugo E Mugisha, J Acquir Immune Defic Syndr 2001 27 381 388 11468427
12. First trial of the HIV-1 vaccine in Africa: Ugandan experience. RD Mugerwa P Kaleebu P Mugyenyi E Katongole-Mbidde DL Hom R Byaruhanga RA Salata JJ Ellner, BMJ 2002 324 226 229 10.1136/bmj.324.7331.226 11809648
13. Willingness to participate in preventive HIV vaccine trials in a community-based cohort in south western Uganda. E Ruzagira S Wandiembe L Bufumbo J Levin MA Price H Grosskurth A Kamali, Trop Med Int Health 2009 14 196 203 10.1111/j.1365-3156.2008.02200.x 19207177
14. HIV vaccine acceptability among women at risk: perceived barriers and facilitators to future HIV vaccine uptake. ET Rudy PA Newman N Duan EM Kelly KJ Roberts DS Seiden, AIDS Educ Prev 2005 17 253 267 10.1521/aeap.17.4.253.66529 16006211
15. Knowledge and attitudes regarding preventative HIV vaccine clinical trials in Italy: results of a national survey. F Starace TM Wagner AM Luzi L Cafaro P Gallo G Rezza, AIDS Care 2006 18 66 72 10.1080/09540120500161777 16282079
16. Willingness to volunteer in future preventive HIV vaccine trials: issues and perspectives from three U.S. communities. RP Strauss S Sengupta S Kegeles E McLellan D Metzger S Eyre F Khanani CB Emrick KM MacQueen, J Acquir Immune Defic Syndr 2001 26 63 71 11176270
17. Public engagement with science? Local understandings of a vaccine trial in the Gambia. J Fairhead M Leach M Small, J Biosoc Sci 2006 38 103 116 10.1017/S0021932005000945 16266443
18. Willingness to participate and enroll in a phase 3 preventive HIV-1 vaccine trial. JM O'Connell RS Hogg K Chan SA Strathdee N McLean SL Martindale B Willoughby R Remis, J Acquir Immune Defic Syndr 2002 31 521 528 12473841
19. Willingness to participate in HIV vaccine trials among HIV-negative gay men in Sydney, Australia. P Van de Ven L Mao J Crawford G Prestage A Grulich J Kaldor S Kippax, Int J STD AIDS 2005 16 314 317 10.1258/0956462053654212 15899086
20. Sub-saharan Africa AIDS epidemic update, regional summary. UNAIDS, Geneva: UNAIDS and WHO 2008
21. International AIDS Vaccine Initiative. Database of AIDS Vaccine Candidates in Clinical Trials. http://www.iavireport.org/trials-db/Pages/ default.aspx
22. Willingness to volunteer in a Phase I/II HIV vaccine trial: a study among police officers in Dar es Salaam, Tanzania. EAM Tarimo A Thorson M Bakari J Mwami E Sandstrom A Kulane, Global Health Action 2009 2 DOI:10.3402/gha.v3402: 3400.1953. 10.3402/gha.v2i0.1953
23. S Thorne, Interpretive Description. Developing Qualitative Inquiry Walnut Greek CA: Left Cost Press Inc. 2008 35 74
24. The prevalence and incidence of HIV-1 infection and syphilis in a cohort of police officers in Dar es Salaam, Tanzania: a potential population for HIV vaccine trials. M Bakari E Lyamuya F Mugusi E Aris S Chale P Magao R Jossiah M Janabi A Swai N Pallangyo E Sandstrom F Mhalu G Biberfeld K Pallangyo, AIDS 2000 14 313 320 10.1097/00002030-200002180-00014 10716508
25. Phase I clinical trial safety of DNA- and modified virus Ankara-vectored human immunodeficiency virus type 1 (HIV-1) vaccines administered alone and in a prime-boost regime to healthy HIV-1-uninfected volunteers. I Cebere L Dorrell H McShane A Simmons S McCormack C Schmidt C Smith M Brooks JE Roberts SC Darwin PE Fast C Conlon S Rowland-Jones AJ Michael T Hanke, Vaccine 2006 24 417 425 10.1016/j.vaccine.2005.08.041 16176847
26. JM Morse L Richards, Reading First: a User's Guide to Qualitative Methods Thousands Oaks: Sage Publications 2002 172 173
27. L Dahlgren M Emmelin A Winkvist, Qualitative Methodology for International Public Health Umea University: Print och Media 2007 33 47
28. D Morgan, Planning Focus Groups. Focus Group Kit2 Thousand Oaks: Sage Publications 1998
29. Willingness of Chinese injection drug users to participate in HIV vaccine trials. L Yin Y Zhang HZ Qian B Rui L Zhang J Zhu Y Guan Y Wang Q Li Y Ruan Y Shao, Vaccine 2008 26 762 768 10.1016/j.vaccine.2007.11.091 18191881
30. The value of children in African countries: insights from studies on infertility. SJ Dyer, J Psychosom Obstet Gynaecol 2007 28 69 77 10.1080/01674820701409959 17538814
31. Motherhood in sub-Saharan Africa: the social consequences of infertility in an urban population in northern Tanzania. M Hollos U Larsen, Cult Health Sex 2008 10 159 173 10.1080/13691050701656789 18247209
32. HIV Vaccine Knowledge and Beliefs among Communities at Elevated Risk: Conspiracies, Questons and Confusion. KJ Roberts PA Newman N Duan ET Rudy, J Natl Med Assoc 2005 97 1662 1671 16396058
33. Determinants of enrollment in a preventive HIV vaccine trial: hypothetical versus actual willingness and barriers to participation. SP Buchbinder B Metch SE Holte S Scheer A Coletti E Vittinghoff, J Acquir Immune Defic Syndr 2004 36 604 612 10.1097/00126334-200405010-00009 15097304
34. Factors associated with willingness to participate in HIV vaccine trials among high-risk populations in South India. M Suhadev AM Nyamathi S Swaminathan A Suresh P Venkatesan, AIDS Res Hum Retroviruses 2009 25 217 224 10.1089/aid.2007.0312 19239362
35. A pilot study on willingness to participate in future preventive HIV vaccine trials. M Suhadev AM Nyamathi S Swaminathan P Venkatesan S Raja M akthivel R Shenbagavalli A Suresh JL Fahey, Indian J Med Res 2006 124 631 640 17287550
36. Tanzania HIV/AIDS and Malaria Indicator Survey 2007-2008. Tanzania Commission for AIDS (TACAIDS), Dar es Salaam: TACAIDS 2008
37. Perceptions of a community sample about participation in future HIV vaccine trials in south India. AM Nyamathi M Suhadev S Swaminathan JL Fahey, AIDS Behav 2007 11 619 627 10.1007/s10461-006-9173-8 17016758
38. Knowledge and attitudes towards HIV vaccines among Soweto adolescents. G de Bruyn N Skhosana G Robertson JA McIntyre GE Gray, BMC Res Notes 2008 1 DOI:10.1186/1756-0500-1-76. 10.1186/1756-0500-1-76 18759973
39. HIV vaccine trial preparedness among Spanish-speaking Latinos in the US. RA Brooks PA Newman N Duan DJ Ortiz, AIDS Care 2007 19 52 58 10.1080/09540120600872711 17129857 (Pubitemid 44868013)
40. Preparedness for AIDS vaccine trials in India. JL Excler S Kochhar S Kapoor S Das J Bahri MD Ghosh NK Ganguly A Nayyar M Chataway, Indian J Medic Res 2008 127 531 538
41. Why Blacks Do Not Take Part in HIV Vaccine Trials. D Mautsiakis N Chin, J Natl Med Assoc 2007 99 254 257 17393949
42. Defining and refining international donor support for combating the AIDS pandemic. A Attaran J Sachs, Lancet 2001 357 57 61 10.1016/S0140-6736(00)03576-5 11197373
43. J Kitzinger, Focus group research: using focus group dynamics to explore perceptions, experiences and understanding Maidenhead Open University Press 2005 56 70
44. Strengths and challenges in the use of interpretive description: reflections arising from a study of the moral experience of health professionals in humanitarian work. MR Hunt, Qual Health Res 2009 19 1284 1292 10.1177/1049732309344612 19690208